H3B-8800, an orally bioavailable modulator of the SF3b complex, shows efficacy in spliceosome-mutant myeloid malignancies Meeting Abstract
| Authors: | Buonamici, S.; Yoshimi, A.; Thomas, M.; Seiler, M.; Chan, B.; Caleb, B.; Darman, R.; Fekkes, P.; Karr, C.; Keaney, G. F.; Klimek, V. M.; Kunii, K.; Lee, L.; Lee, S. C. W.; Liu, X.; Meeske, C.; Mizui, Y.; Padron, E.; Park, E.; Pazolli, E.; Prajapati, S.; Taylor, J.; Wang, J.; Warmuth, M.; Yu, L.; Zhu, P.; Abdel-Wahab, O.; Smith, P. G. |
| Abstract Title: | H3B-8800, an orally bioavailable modulator of the SF3b complex, shows efficacy in spliceosome-mutant myeloid malignancies |
| Meeting Title: | 58th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 128 |
| Issue: | 22 |
| Meeting Dates: | 2016 Dec 3-6 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2016-12-01 |
| Language: | English |
| ACCESSION: | WOS:000394446805007 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V128.22.966.966 |
| Notes: | Meeting Abstract: 966 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
147Klimek -
573Abdel-Wahab -
43Lee -
35Yoshimi -
51Taylor
Related MSK Work